9 Jun 2026Open access
Albumin–Bilirubin Grade and HIV Status in Hepatocellular Carcinoma as Predictors of Survival in ZimbabwePublisher siteLivers, Hepatocellular Carcinoma Treatment and Prognosis
UniversitiesTinashe Mazhindu
Active, last published 2026
In pharmacogenetics and drug metabolism
Tinashe
Mazhindu
Scholar“Research focused on Pharmacogenetics and Drug Metabolism and adjacent fields.”
University of Zimbabwe
Claim Your Profile5
H-index
80
Citations
Tinashe has not officially claimed their profile. If you are Tinashe, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
inashe Mazhindu is a researcher working on Pharmacogenetics and Drug Metabolism. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Tinashe's work has been cited 80 times across 1 active year. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Pharmacogenetics and Drug Metabolism×8Colorectal Cancer Treatments and Studies×5Global Cancer Incidence and Screening×4Cancer Treatment and Pharmacology×3Prostate Cancer Diagnosis and Treatment×2
04 · Where I am
Affiliations
Affiliation on published researchUniversity of ZimbabweDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
4 works3 Apr 2026Open access1cites
Actionable Pharmacogenomics and Essential Medicines: An Analysis of WHO and African Lists for Safer and Efficacious Drug UsePublisher siteClinical Pharmacology & Therapeutics, Pharmacogenetics and Drug Metabolism
3 Apr 2026Open access1cites
The Burden of Adverse Drug Reactions in Africa in the Context of Pharmacogenetics‐Based Clinical GuidelinesPublisher siteClinical Pharmacology & Therapeutics, Pharmacogenetics and Drug Metabolism
1 Feb 2026Open access
A Pharmacogenomic Basis for Tolerance of 5-Fluorouracil Following Early, Severe Toxicity from Capecitabine in a CDA Ultrarapid Metabolizer Colon Cancer Patient: A Case ReportPublisher siteCancer Management and Research, Colorectal Cancer Treatments and Studies
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Tinashe?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you